HeartFlow is the creator of a cardiac diagnostic platform designed to revolutionize the diagnosis and treatment of coronary artery diseases. This platform utilizes data from regular computerized tomography scans to generate a personalized three-dimensional model of arteries. It further analyzes the effects of blockages on blood flow. This innovative approach enables clinicians to effectively treat patients suffering from significant coronary artery disease while minimizing unnecessary invasive testing.

Investors Include:

US Venture Partners, Hayfin Capital Management, Wellington Management, Emergent Medical Partners, InterAlpen Partners, Spur Capital Partners, Panorama Point Partners, Bain Capital, Sandbox Industries, Lifeforce Capital, Baillie Gifford, Sweetwater Private Equity, Rancilio Cube, HealthCare Ventures, SeedFord Partners, Venture Science, Martis Capital Management, Mark Carlson, HealthCor Partners Management, Fogarty Innovation, Blue Venture Fund, Capricorn Investment Group, Mont Alto Capital, Thomas Hawes, Brookside Equity Partners.

Looking to sell HeartFlow Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you